Jul 5, 2016 8:31 am EDT iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate
Jun 29, 2016 8:31 am EDT iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis
Jun 7, 2016 8:31 am EDT Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals
Jan 14, 2016 9:00 am EST iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment
Nov 19, 2015 8:31 am EST Scientific Insights Into IBIO-CFB03 Presented at American College of Rheumatology Annual Meeting